Core Insights - National Vision (EYE) is currently rated as a 2 (Buy) by Zacks Rank, while Hermes International SA (HESAY) is rated as a 4 (Sell), indicating a more favorable earnings estimate revision trend for EYE [3] - Value investors typically assess various fundamental metrics to identify undervalued stocks, including P/E ratio, P/S ratio, earnings yield, and cash flow per share [4] Valuation Metrics - EYE has a forward P/E ratio of 30.39, compared to HESAY's forward P/E of 45.24, suggesting EYE is more attractively priced [5] - EYE's PEG ratio is 1.10, while HESAY's PEG ratio is significantly higher at 3.66, indicating EYE's expected earnings growth is more favorable [5] - EYE's P/B ratio stands at 2.53, whereas HESAY has a P/B ratio of 13.96, further supporting EYE's valuation attractiveness [6] Conclusion - Given the stronger estimate revision activity and more appealing valuation metrics, EYE is positioned as the superior choice for value investors compared to HESAY [7]

Investors with an interest in Utility - Electric Power stocks have likely encountered both Portland General Electric (POR) and E.ON SE (EONGY) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The Zacks Rank is a proven strategy ...

Investors interested in Diversified Operations stocks are likely familiar with Sumitomo Corp. (SSUMY) and Honeywell International Inc. (HON) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank is a proven strategy that targets companies with positive earnings est ...

Investors interested in stocks from the Electronics - Miscellaneous Components sector have probably already heard of Alps Electric (APELY) and Littelfuse (LFUS) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank favors stock ...

Core Viewpoint - Investors in the Financial - Miscellaneous Services sector should consider Grupo Financiero Banorte SAB de CV (GBOOY) and American Express (AXP) for potential undervalued stock opportunities [1] Group 1: Zacks Rank and Earnings Estimates - GBOOY has a Zacks Rank of 2 (Buy), while AXP has a Zacks Rank of 3 (Hold), indicating a stronger earnings outlook for GBOOY [3] - The Zacks Rank system emphasizes companies with positive earnings estimate revisions, suggesting GBOOY is likely experiencing an improved earnings outlook [3] Group 2: Valuation Metrics - GBOOY has a forward P/E ratio of 8.96, significantly lower than AXP's forward P/E of 19.77, indicating GBOOY may be undervalued [5] - GBOOY's PEG ratio is 1.11, compared to AXP's PEG ratio of 1.46, suggesting GBOOY offers better value relative to its expected earnings growth [5] - GBOOY's P/B ratio is 2.35, while AXP's P/B ratio is 7.1, further indicating GBOOY's more attractive valuation metrics [6] Group 3: Overall Value Assessment - GBOOY has a Value grade of A, while AXP has a Value grade of C, reinforcing the conclusion that GBOOY is the superior option for value investors at this time [6][7]

Investors interested in Medical - Drugs stocks are likely familiar with USANA Health Sciences (USNA) and United Therapeutics (UTHR) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank favors stocks with strong earnings estimate revision ...

Core Viewpoint - Investors in the Medical - Instruments sector may find value in either Globus Medical (GMED) or Masimo (MASI), with a closer examination needed to determine which stock is more appealing to value investors [1] Valuation Metrics - Both GMED and MASI currently hold a Zacks Rank of 2 (Buy), indicating positive revisions to their earnings estimates and improving earnings outlooks [3] - The Value category assesses undervalued companies using key metrics such as P/E ratio, P/S ratio, earnings yield, and cash flow per share [4] - GMED has a forward P/E ratio of 22.92 and a PEG ratio of 1.45, while MASI has a forward P/E of 30.36 and a PEG ratio of 1.77 [5] - GMED's P/B ratio is 2.77, contrasting with MASI's P/B of 11.61, indicating GMED is more favorably valued [6] - Based on these valuation metrics, GMED is rated with a Value grade of B, while MASI has a Value grade of D, suggesting GMED is the superior value option [6]

Asia Value & Moat Stocks is a research service for value investors seeking Asia-listed stocks with a huge gap between price and intrinsic value, leaning towards deep value balance sheet bargains (i.e. buying assets at a discount e.g. net cash stocks, net-nets, low P/B stocks, sum-of-the-parts discounts) and wide moat stocks (i.e. buying earnings power at a discount in great companies like "Magic Formula" stocks, high-quality businesses, hidden champions and wide moat compounders). Sign up here to get starte ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors use fundamental analysis and ...

Core Insights - The article emphasizes the importance of the Zacks Rank system in identifying winning stocks through earnings estimates and revisions, while also considering trends in value, growth, and momentum [1] Company Analysis - Nutrien (NTR) is highlighted as a stock to watch, currently holding a Zacks Rank of 2 (Buy) and an A for Value, indicating strong potential for value investors [4] - NTR has a Forward P/E ratio of 12.54, which is lower than the industry average of 14.48, suggesting it may be undervalued [4] - Over the past year, NTR's Forward P/E has fluctuated between 11.92 and 15.98, with a median of 13.47, indicating variability in market perception [4] - The company has a PEG ratio of 0.86, compared to the industry average of 1.39, which suggests that NTR is undervalued relative to its expected earnings growth [5] - NTR's PEG ratio has ranged from 0.86 to 1.67 over the past year, with a median of 1.07, further supporting its valuation appeal [5] - The P/S ratio for NTR is 1.27, which is lower than the industry average of 1.45, reinforcing the notion that the stock is likely undervalued [6] - These metrics contribute to NTR's strong Value grade, indicating that it is an impressive value stock with a favorable earnings outlook [7]